Translating Landmark and Meta-Analyses Trials in CGM to the Front Lines of Diabetes Care: Focus on the Role of Sensor-Based Technology to Improve Time in Range and Interpretation of Ambulatory Glucose Profiles. The Evidence for CGM to Improve Safety, Outcomes, HbA1c Target Goal Attainment and Patient Satisfaction in Persons with Diabetes